Viewing Study NCT02114957


Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2026-01-01 @ 3:52 PM
Study NCT ID: NCT02114957
Status: COMPLETED
Last Update Posted: 2014-04-15
First Post: 2014-04-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics of Decursin/Decursinol Angelate (CognIQTM)
Sponsor: Texas Tech University Health Sciences Center
Organization:

Study Overview

Official Title: Single Oral Dose Pharmacokinetics of Decursin/Decursinol Angelate in Healthy Adult Men and Women
Status: COMPLETED
Status Verified Date: 2014-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is to investigate how human bodies absorb and metabolize two herbal drugs. The information is critical for drug development and could not be obtained from any other studies using animals. The two herbal drugs are decursin and decursinol angelate (DA) which naturally exist in a traditional herb Angelica gigas Nakai (AGN). Preclinical and clinical studies indicated that AGN and decursin/DA were quite safe to animals and human.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: